Asymptomatic Anal Lgv Infection clinical trials

Explore recruiting asymptomatic anal lgv infection clinical trials.

Also recruiting in Europe

Asymptomatic Anal Lgv Infection trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Multicentre study evaluating the efficacy of a 7-day course of doxycycline for the treatment of asymptomatic anal lymphogranuloma venereum SHORT-LGV

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Asymptomatic Anal Lgv Infection trials by city

Asymptomatic Anal Lgv Infection in Toronto Asymptomatic Anal Lgv Infection in Vancouver Asymptomatic Anal Lgv Infection in Montreal Asymptomatic Anal Lgv Infection in Calgary Asymptomatic Anal Lgv Infection in Edmonton Asymptomatic Anal Lgv Infection in Ottawa Asymptomatic Anal Lgv Infection in Winnipeg Asymptomatic Anal Lgv Infection in Quebec City Asymptomatic Anal Lgv Infection in Hamilton Asymptomatic Anal Lgv Infection in Kitchener Asymptomatic Anal Lgv Infection in London Asymptomatic Anal Lgv Infection in Halifax Asymptomatic Anal Lgv Infection in New York Asymptomatic Anal Lgv Infection in Los Angeles Asymptomatic Anal Lgv Infection in Chicago Asymptomatic Anal Lgv Infection in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease